Dr Jack Prow Clark, MD | |
518 Ems D15 Ln, Syracuse, IN 46567-8026 | |
(574) 457-3292 | |
Not Available |
Full Name | Dr Jack Prow Clark |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 518 Ems D15 Ln, Syracuse, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346320140 | NPI | - | NPPES |
01017687B | Other | IN | CSR CERTIFICATE |
AC2674922 | Other | IN | BNDD NUMBER |
01017687A | Other | IN | MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01017687 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jack Prow Clark, MD 518 Ems D15 Ln, Syracuse, IN 46567-8026 Ph: (574) 457-3292 | Dr Jack Prow Clark, MD 518 Ems D15 Ln, Syracuse, IN 46567-8026 Ph: (574) 457-3292 |
News Archive
The Mount Sinai Medical Center has become the first hospital in the United States to perform a cardiac catheterization procedure using the TactiCath force-sensing ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation, or periodic rapid and irregular heartbeats.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on endotoxin detection at the American Society for Microbiology General Meeting, June 16-19, 2012, in San Francisco, CA.
In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.
ArQule, Inc. today announced the pricing of an underwritten public offering of 7,150,000 shares of its common stock at a price of $7.30 per share.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 2 days ago
John Kent Kratzer, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 W Pickwick Dr, Ste A, Syracuse, IN 46567 Phone: 574-457-8585 Fax: 574-457-8755 | |
Matthew Wells, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1033 N Indiana Ave, Syracuse, IN 46567 Phone: 574-457-5701 | |
Karla Troyer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1033 N Indiana Ave, Syracuse, IN 46567 Phone: 574-457-5701 Fax: 574-457-5609 | |
Jodi S Clouse, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1033 North Indiana Avenue, Syracuse, IN 46567 Phone: 574-457-5701 Fax: 574-457-5609 | |
Larry D Allen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1033 N Indiana Ave, Syracuse, IN 46567 Phone: 574-457-5701 Fax: 574-457-5609 |